8 | AntigensIBA
02/2024
-
12/2020 |
5 | RadiopharmaceuticalsIBA
02/2024
-
01/2017 |
4 | LigandsIBA
01/2021
-
04/2006 |
4 | 18F-FC119SIBA
04/2020
-
01/2017 |
3 | Estrogen ReceptorsIBA
05/2007
-
08/2003 |
2 | AlbuminsIBA
02/2024
-
12/2021 |
2 | Radioisotopes (Radionuclides)IBA
01/2023
-
08/2003 |
2 | Amino AcidsFDA Link
09/2021
-
02/2018 |
2 | Tyrosine (L-Tyrosine)FDA Link
09/2021
-
02/2018 |
2 | Urea (Carbamide)FDA LinkGeneric
12/2020
-
07/2013 |
2 | Amyloid (Amyloid Fibrils)IBA
04/2020
-
01/2018 |
2 | 2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
04/2020
-
03/2017 |
2 | ProdrugsIBA
02/2015
-
10/2013 |
2 | F 4 (F-4)IBA
10/2013
-
01/2007 |
2 | Non-Steroidal Estrogens (Estrogens, Non Steroidal)IBA
05/2009
-
05/2007 |
2 | Peptides (Polypeptides)IBA
04/2008
-
03/2005 |
2 | IntegrinsIBA
04/2008
-
12/2006 |
2 | Integrin alphaVIBA
12/2006
-
03/2005 |
1 | Chelating AgentsIBA
08/2023 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
08/2023 |
1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
08/2023 |
1 | 2- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA
01/2023 |
1 | AT 112IBA
01/2023 |
1 | AcidsIBA
01/2023 |
1 | gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
01/2022 |
1 | LutetiumIBA
12/2021 |
1 | GalliumIBA
12/2021 |
1 | Biomarkers (Surrogate Marker)IBA
01/2021 |
1 | piperidineIBA
01/2021 |
1 | LipopolysaccharidesIBA
01/2021 |
1 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2021 |
1 | 2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
01/2018 |
1 | Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2018 |
1 | Amyloid beta-PeptidesIBA
03/2017 |
1 | Dopamine (Intropin)FDA LinkGeneric
01/2016 |
1 | Caspase 3 (Caspase-3)IBA
02/2015 |
1 | cytochrome P-450 CYP4B1 (CYP4B1)IBA
10/2013 |
1 | EnzymesIBA
10/2013 |
1 | 4-ipomeanolIBA
10/2013 |
1 | compound 18IBA
07/2013 |
1 | 1- (2- methyl- 3- hydroxy- 5- hydroxymethyl- 4- pyridyl)- 6,7- dihydroxy- 1,2- 3,4- tetrahydroisoquinolineIBA
04/2012 |
1 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
04/2012 |
1 | Estrogen Receptor betaIBA
05/2009 |
1 | HalogensIBA
05/2009 |
1 | arginyl-glycyl-aspartic acidIBA
04/2008 |
1 | glycol-chitosanIBA
04/2008 |
1 | PorphyrinsIBA
12/2007 |
1 | Estrogens (Estrogen)FDA Link
05/2007 |
1 | Glucosamine (Dona)IBA
12/2006 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
12/2006 |
1 | Fluorine-18IBA
04/2006 |
1 | FluorineIBA
04/2006 |
1 | CyclofenilIBA
04/2006 |
1 | Integrin beta3 (GPIIIa)IBA
03/2005 |
1 | phoroneIBA
03/2004 |
1 | diallyl disulfide (diallyl disulphide)IBA
03/2004 |
1 | Sulfhydryl Compounds (Thiols)IBA
03/2004 |
1 | dibenzyl disulfideIBA
03/2004 |
1 | DisulfidesIBA
03/2004 |
1 | methyl methanethiosulfonate (MMTS)IBA
03/2004 |
1 | benzylguanidineIBA
01/2004 |
1 | 3-Iodobenzylguanidine (Iobenguane)IBA
01/2004 |
1 | formylchromoneIBA
08/2003 |